Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes
Open accessThe DOI matches its Crossref record; 284 of the 288 references it cites were found in a registry or an index.
Abstract
This paper reviews the findings from preclinical animal and human clinical research investigating maternal/fetal, neonatal, and child neurodevelopmental outcomes following prenatal exposure to psychotropic drugs. Evidence for the risks associated with prenatal exposure was examined, including teratogenicity, neurodevelopmental effects, neonatal toxicity, and long-term neurobehavioral consequences (i.e., behavioral teratogenicity). We conducted a comprehensive review of the recent results and conclusions of original research and reviews, respectively, which have investigated the short- and long-term impact of drugs commonly prescribed to pregnant women for psychological disorders, including mood, anxiety, and sleep disorders. Because mental illness in the mother is not a benign event, and may itself pose significant risks to both mother and child, simply discontinuing or avoiding medication use during pregnancy may not be possible. Therefore, prenatal exposure to psychotropic drugs is a major public health concern. Decisions regarding drug choice, dose, and duration should be made carefully, by balancing severity, chronicity, and co-morbidity of the mental illness, disorder, or condition against the potential risk for adverse outcomes due to drug exposure. Globally, maternal mental health problems are considered as a major public health challenge, which requires a stronger focus on mental health services that will benefit both mother and child. More preclinical and clinical research is needed in order to make well-informed decisions, understanding the risks associated with the use of psychotropic medications during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BZD use in pregnancy has been found to be associated with an increased risk of miscarriage, preterm birth, and low birth weight.175–177”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [175]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antenatal exposure to BZDs is not associated with major congenital malformations.175,178”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [175]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although BZD use during pregnancy may carry some risk to the fetus, similar risks are also present if patient anxiety, mood, and sleep disorders are left untreated, including an increase in miscarriage, preterm birth, and low birth weight.175,186”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [175]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Grote, N. K., Bridge, J. A., Gavin, A. R., Melville, J. L., Iyengar, S., & Katon, W. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.111 · Cited by 1,882 · cited 1×
“• Bipolar I and II • Bipolar NOS • Cyclothymia 3–7% [7] 25 years 25–30% of pregnant women experience episodes [22,42] • low birthweight, size at birth, preterm birth [25,26] • risk of cesarean birth, small head circumference, hypoglycemia [26] • risk for long-term neurocognitive, behavioral and social deficits [27–29]…”
BackgroundCohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,280
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Van den Bergh, B. R. H., van den Heuvel, M. I., Lahti, M., Braeken, M., de Rooij, S. R., Entringer, S., Hoyer, D., Roseboom, T., Räikkönen, K., King, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.003 · Cited by 1,181
Epidemiology of Puerperal Psychoses
Kendell, R. E., Chalmers, J. C., & Platz, C. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.5.662 · Cited by 1,119
Van den Bergh, B. R. H., Mulder, E. J. H., Mennes, M., & Glover, V. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.007 · Cited by 1,104 · cited 2×
“ANXIETY DISORDERS • Generalized Anxiety Disorder (GAD) • Panic Disorders • Social Anxiety Disorder • Specific Phobias • increased risk for preterm birth, small for gestational age [39–41] • spontaneous abortion [42] • pre-eclampsia, deceased head circumference [43], low birth weight [44] • excessive infant crying [45]…”
BackgroundPsychiatric Disorders in Pregnant and Postpartum Women in the United States
Vesga-López, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.805 · Cited by 1,065 · cited 1×
“3% would meet criteria for a psychiatric disorder [5].”
BackgroundA Prospective Study of Emotional Disorders in Childbearing Women
Kumar, R., & Robson, K. M. (1984) · British Journal of Psychiatry · doi:10.1192/bjp.144.1.35 · Cited by 980 · cited 1×
“For example, it has been reported both that pregnant women experience highest level of depressive symptoms between 34 and 38 weeks gestation [8], and also that there is an improvement in mood during the second and third trimesters [9,10].”
Background
Research works printed but not linked: 2
- National Center for Health Statistics (US) (2019, August 01). Health, United States, 2014: With Special Feature on Adults Aged 55–64. Hyattsville (MD): National Center for Health Statistics (US), Available online: https://www.ncbi.nlm.nih.gov/books/NBK299348/.
- Christiaens, 1999, Antiepileptic drug regimens and major congenital abnormalities in the offspring, Ann. Neurol., 46, 739, 10.1002/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2 · doi:10.1002/1531-8249(199911)46:5<739::aid-ana9>3.0.co;2-2
Cited by
Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When
Hanna-Jairala, I., & Drossman, D. A. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002800 · Cited by 77
Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“175,186 In general, existing clinical guidelines recommend optimizing alternative therapeutic approaches (e.g., CBT, CBT-I) and advise caution with BZD dosing during pregnancy.”
Women's Mental Health Services and Pregnancy: A Review
Ghahremani, T., Magann, E. F., Phillips, A., Ray-Griffith, S. L., Coker, J. L., & Stowe, Z. N. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000994 · Cited by 37
Should Antidepressants be Avoided in Pregnancy?
Besag, F., & Vasey, M. J. (2022) · Drug Safety · doi:10.1007/s40264-022-01257-1 · Cited by 33
Ge, R., Sassi, R. B., Yatham, L. N., & Frangou, S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01925-9 · Cited by 24
Metadata
- Authors
- Creeley, C. E., & Denton, L. K.
- Affiliations
- SUNY Fredonia (US)
- Corresponding author
- Creeley, Catherine E.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2019-09-14
- Volume
- 9
- Issue
- 9
- Pages
- 235
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC6770670
- OpenAlex
- W2973068236
- Cited by
- 78
- References
- 288
- Citations by year
- 2026: 7 · 2025: 27 · 2024: 14 · 2023: 10 · 2022: 11 · 2021: 8 · 2020: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- psychotropic drugs, pregnancy, prenatal drug exposure, teratogenicity, neonatal toxicity, neurodevelopmental outcomes, maternal mental health, mood disorders, anxiety disorders, sleep disorders, drug use in pregnancy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes. https://app.cochat.ai/papers/10.3390/brainsci9090235
- The paper
- Creeley, C. E., & Denton, L. K. (2019). Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes. Brain Sciences. https://doi.org/10.3390/brainsci9090235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.